Cancer Genetics – News and Features

A new drug developed for treating melanoma and lung cancer can also stop the progression of cutaneous squamous cell carcinoma, for which there are currently no targeted treatments.

Treating cancer is becoming increasingly complex, but also offers more and more possibilities. After all, the better a tumor’s biology and genetic features are understood, the more treatment approaches there are.

A diverse array of biological medicines are now used to prevent and treat a wide range of illnesses. This article will discuss the development of cell lines in biopharma and will touch on key considerations, such as future manufacturability.

A study of newly created databases of medulloblastoma has found that patients with tumors containing circular extrachromosomal DNA are twice as likely to relapse and three times as likely to die within five years of diagnosis.

Researchers have released a groundbreaking study identifying 4,749 key gene clusters, termed “prognostic modules,” that significantly influence the progression of 32 different types of cancer.

The largest and most diverse investigation into prostate cancer genetics yet, which included major increases in representation among men from different racial and ethnic groups, has revealed 187 new risk variants.

New research has discovered that breast cancer cells expressing the Myc gene rely heavily on vitamin B5 to grow and survive, which could potentially be exploited as a therapeutic avenue.

Vaccinating both girls and boys against HPV is the best way to prevent cervical cancer, reports a new study. Gender-neutral vaccination induces herd immunity that will help to eradicate cancer-causing virus types.

A new study has revealed that tobacco smoke can cause specific DNA changes that can prevent anti-cancer proteins from being fully constructed, representing one way that tobacco smoking causes cancer.

An international team of researchers has discovered that formaldehyde, a widely spread pollutant and common metabolite in our body, interferes in the epigenetic programming of the cell.